A genetic polymorphism of MAO-B modifies the association of cigarette smoking and Parkinson's disease

被引：77
|
作者：
Checkoway, H
Franklin, GM
Costa-Mallen, P
Smith-Weller, T
Dilley, J
Swanson, PD
Costa, LG
机构：
[1] Univ Washington, Dept Environm Hlth, Seattle, WA 98195 USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[3] Univ Washington, Dept Neurol, Seattle, WA 98195 USA
来源：
NEUROLOGY | 1998年 / 50卷 / 05期
关键词：
D O I：
10.1212/WNL.50.5.1458
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
In a population-based case-control study, we found a reversal of the association of cigarette smoking with Parkinson's disease (PD) in relation to the monoamine oxidase B intron 13 genetic polymorphism. A reduced PD risk related to pack-years of smoking was detected for persons with the G allele, whereas an opposite effect was found among persons with the A allele. These results indicate an unexplained interaction between cigarette smoking and this genetic polymorphism.
引用
收藏
页码：1458 / 1461
页数：4
相关论文
共 50 条
  • [1] Association of MAO-B intron 13 polymorphism with smoking and risk for Parkinson's disease
    Gu Z. Q.
    Chan P.
    JOURNAL OF NEUROCHEMISTRY, 2006, 98 : 117 - 117
  • [2] Genetic polymorphism of dopamine D2 receptors in Parkinson's disease and interactions with cigarette smoking and MAO-B intron 13 polymorphism
    Costa-Mallen, P
    Costa, LG
    Smith-Weller, T
    Franklin, GM
    Swanson, PD
    Checkoway, H
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (04): : 535 - 537
  • [3] The ''protective'' effect of smoking in Parkinson's disease is modified by an MAO-B polymorphism
    Franklin, GM
    Checkoway, H
    CostaMallen, P
    Swanson, PD
    SmithWeller, T
    Levy, D
    Costa, LG
    NEUROLOGY, 1997, 48 (03) : 42006 - 42006
  • [4] Parkinson's disease and monoamine oxidases A and B: Association with MAO-B alleles.
    Parsian, A
    Racette, B
    Zhang, ZH
    Rundle, M
    Perlmutter, JS
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A465 - A465
  • [5] COMT and MAO-B gene polymorphism in relation to psychotic symptoms in Parkinson's disease
    Katsarou, Z.
    Fidani, L.
    Kourtesi, G.
    Kallinderi, K.
    Tsipropoulou, V.
    Bostantjopoulou, S.
    MOVEMENT DISORDERS, 2014, 29 : S318 - S319
  • [6] Parkinson's disease: New inhibitor of MAO-B
    Eich, Peter
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2006, 74 (12) : 750 - 750
  • [7] MAO-B Polymorphism Associated with Progression in a Chinese Parkinson's Disease Cohort but Not in the PPMI Cohort
    Cui, Shi-Shuang
    Wu, Ling-Yu
    Li, Gen
    Du, Juan-Juan
    Huang, Pei
    Liu, Jin
    Ling, Yun
    Ren, Kang
    Chen, Zhong-Lue
    Chen, Sheng-Di
    PARKINSONS DISEASE, 2022, 2022
  • [8] Monoamine oxidase B polymorphism, cigarette smoking, and risk of Parkinson's disease
    Tan, EK
    Chai, A
    Zhao, Y
    Wong, MC
    MOVEMENT DISORDERS, 2002, 17 : S35 - S35
  • [9] Predictive value of a functional polymorphism in intron 13 of the MAO-B gene for dyskinesias in Parkinson's disease
    Loehle, Matthias
    Mangone, Graziella
    Hermann, Wiebke
    Hausbrand, Denise
    Wolz, Martin
    Mende, Julia
    Reichmann, Heinz
    Hermann, Andreas
    Corvol, Jean-Christophe
    Storch, Alexander
    JOURNAL OF NEURAL TRANSMISSION, 2019, 126 (05) : 689 - 689
  • [10] Platelet MAO activities and MAO-B protein concentrations in Parkinson's disease and controls
    Finch, CC
    Ho, SL
    Williams, AC
    Billett, EE
    CURRENT NEUROCHEMICAL AND PHARMACOLOGICAL ASPECTS OF BIOGENIC AMINES, 1995, 106 : 85 - 90
12345